Salem Investment Counselors’s Cytosorbents Corp CTSO Stock Holding History

Salem Investment Counselors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$80K	–	864
2020 Q4	$80K	Buy	+10,000	New	+$83.7K	0.01%	374
2019 Q3	–	Sell	-13,000	Closed	-$86K	–	648
2019 Q2	$86K	Hold	13,000	–	–	0.01%	313
2019 Q1	$168K	Hold	13,000	–	–	0.02%	201
2018 Q4	$105K	Hold	13,000	–	–	0.01%	183
2018 Q3	$168K	Hold	13,000	–	–	0.02%	201
2018 Q2	$148K	Hold	13,000	–	–	0.01%	211
2018 Q1	$90K	Hold	13,000	–	–	0.01%	236
2017 Q4	$85K	Hold	13,000	–	–	0.01%	256
2017 Q3	$79K	Hold	13,000	–	–	0.01%	257
2017 Q2	$56K	Hold	13,000	–	–	0.01%	301
2017 Q1	$59K	Buy	+13,000	New	+$72.6K	0.01%	369

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Salem Investment Counselors's CTSO Position: Q1 2021 in Review

Salem Investment Counselors sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 10,000 shares — an estimated $80K sold.

Salem Investment Counselors first reported a position in CTSO in Q1 2017 and held it in 11 quarters. The position peaked at $168K in Q1 2019. 96 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

Salem Investment Counselors reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
Salem Investment Counselors sold 10,000 Cytosorbents Corp shares in Q1 2021, an estimated $80K.
Salem Investment Counselors first reported a position in Cytosorbents Corp in Q1 2017 and held it in 11 quarters.
Salem Investment Counselors's Cytosorbents Corp position peaked at $168K in Q1 2019.
96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Salem Investment Counselors's 13F filing for Q1 2021, filed 17 May 2021.